We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Novel App Screens for Anemia without Blood Test

By HospiMedica International staff writers
Posted on 27 Sep 2016
Image: The HemaApp measures hemoglobin levels by illuminating a finger with a smartphone’s camera flash (Photo courtesy of Dennis Wise / UW).
Image: The HemaApp measures hemoglobin levels by illuminating a finger with a smartphone’s camera flash (Photo courtesy of Dennis Wise / UW).
Hemoglobin levels and anemia can be construed non-invasively by illuminating a patient’s finger with a smartphone camera flash, according to a new study.

The HemaApp smartphone application, under development at the University of Washington (UW; Seattle, USA), shines light through a patient’s finger at different wavelengths, as well as infrared (IR) energy, to create a series of videos. By analyzing color absorption and reflectance across the different wavelengths, it detects concentrations of hemoglobin and other blood components, such as plasma. Processing algorithms also use pulse to distinguish between the properties of the patient’s blood and the physical characteristics of the finger.

The researchers tested the app under three different scenarios: using the smartphone camera’s flash alone, in combination with a common incandescent light bulb providing ambient light, and with a low-cost light emitting diode (LED) lighting attachment. The additional illumination sources are used to take advantage of properties found in other wavelengths of the electromagnetic spectrum that present useful absorption properties, but that are not currently found on all smartphone cameras.

In the initial trials, the correlation between HemaApp and the patient’s hemoglobin count on a complete blood count (CBC) test using the smartphone camera alone was 69%, with a common incandescent light bulb the correlation was 74%, and when used with the LED attachment, the correlation was 82%. For comparison, the Masimo (Irvine, CA, USA) Pronto showed a correlation of 81% to the CBC. The study was presented at the International Joint Conference on Pervasive and Ubiquitous Computing (UbiComp), held during September 2016 in Heidelberg (Germany).

“New phones are beginning to have more advanced infrared and multi-color LED capabilities; but what we found is that even if your phone doesn’t have all that, you can put your finger near an external light source like a common light bulb and boost the accuracy rates,” said senior author Professor Shwetak Patel, PhD, of the department of computer science & engineering and electrical engineering. “We’re just starting to scratch the surface here. There’s a lot that we want to tackle in using phones for non-invasively screening disease.”

Related Links:
University of Washington
Masimo

Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hybrid Arch Device
Neo EDE
Patient Monitoring System
AlarmSense

Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more